Prevalence of metabolic syndrome and associated factors among patients with chronic Chagas disease.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 28 05 2020
accepted: 12 03 2021
entrez: 2 4 2021
pubmed: 3 4 2021
medline: 16 9 2021
Statut: epublish

Résumé

The increase in life expectancy and the migration of individuals with Chagas disease (ChD) from rural to urban centers exposes them to the development of chronic-degenerative abnormalities that may increase the prevalence of metabolic syndrome (MetS). The present study aimed to identify the prevalence of MetS and its components in individuals with chronic ChD. This is a cross-sectional study with 361 patients of both sexes, aging >18 years, followed at a national reference center (Rio de Janeiro, Brazil). MetS diagnosis followed the International Diabetes Federation 2005 criteria. The association between the variables was determined through logistic regression models. The mean age was and 60.7±10.8 years. About half (56.2%) were female and the majority self-reported their race as mulatto (59.8%). The percentage of individuals with MetS was 40.4%. The variables independently associated with MetS were age (OR 1.06; 95%CI 1.04-1.09), high education levels (OR 0.36; 95%CI 0.17-0.79) and cardiac form with heart failure (OR 0.34; 95%CI 0.17-0.68). Therefore, a high prevalence of MetS was found in this Brazilian chronic ChD cohort. The identification of the associated factors can facilitate the development of effective approaches for preventing and managing MetS in ChD patients.

Identifiants

pubmed: 33798206
doi: 10.1371/journal.pone.0249116
pii: PONE-D-20-16190
pmc: PMC8018626
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0249116

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Negl Trop Dis. 2012;6(2):e1508
pubmed: 22348163
Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:31-40
pubmed: 19753455
BMC Public Health. 2015 Dec 26;15:1299
pubmed: 26856811
BMC Public Health. 2016 Aug 26;16:888
pubmed: 27562190
Arq Bras Cardiol. 2014 Mar;102(3):263-9
pubmed: 24676226
Cad Saude Publica. 2013 Jun;29(6):1141-8
pubmed: 23778546
BMJ Open. 2019 Sep 27;9(9):e027326
pubmed: 31562141
JAMA. 2015 May 19;313(19):1973-4
pubmed: 25988468
Rev Soc Bras Med Trop. 2009 Nov-Dec;42(6):622-8
pubmed: 20209343
Arq Bras Cardiol. 2018 May;110(5):455-466
pubmed: 29898045
Parasit Vectors. 2018 Jun 19;11(1):354
pubmed: 29914550
Rev Saude Publica. 2000 Jun;34(3):251-8
pubmed: 10920447
Curr Hypertens Rep. 2018 Feb 26;20(2):12
pubmed: 29480368
BMC Endocr Disord. 2014 Feb 01;14:9
pubmed: 24484869
Rev Soc Bras Med Trop. 2017 Nov-Dec;50(6):795-804
pubmed: 29340457
Eur J Heart Fail. 2013 Feb;15(2):228-36
pubmed: 23109650
JAMA. 2002 Jan 16;287(3):356-9
pubmed: 11790215
Med Sci Sports Exerc. 2016 Feb;48(2):235-44
pubmed: 26322556
Diabetol Metab Syndr. 2020 Jan 7;12:2
pubmed: 31921359
Int J Epidemiol. 2005 Apr;34(2):316-26
pubmed: 15737978
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Physiol Rev. 1995 Jul;75(3):473-86
pubmed: 7624391
Diabetes Care. 2004 Feb;27(2):613-4
pubmed: 14747248
Circ Heart Fail. 2017 Sep;10(9):
pubmed: 28899988
Arq Bras Endocrinol Metabol. 2007 Oct;51(7):1143-52
pubmed: 18157391
Card Fail Rev. 2015 Oct;1(2):128-131
pubmed: 28785446
Front Public Health. 2019 Jul 02;7:166
pubmed: 31312626
Int J Cardiol. 2018 May 15;259:216-219
pubmed: 29472026
Metab Syndr Relat Disord. 2018 Oct;16(8):416-424
pubmed: 29975597
Lancet Public Health. 2020 Mar;5(3):e140-e149
pubmed: 32007134
Popul Dev Rev. 2011;37(2):307-32
pubmed: 21984851
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
PLoS Negl Trop Dis. 2010 May 18;4(5):e688
pubmed: 20502520
Acta Trop. 2015 Nov;151:16-20
pubmed: 26187358
Trop Med Int Health. 2012 May;17(5):595-603
pubmed: 22487303
Diabetes. 1988 Dec;37(12):1595-607
pubmed: 3056758

Auteurs

Isis Gabrielli Gomes Xavier (IGG)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Marcelo Carvalho Vieira (MC)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Center for Cardiology and Exercise, Aloysio de Castro State Institute of Cardiology, Rio de Janeiro, RJ, Brazil.

Luiz Fernando Rodrigues Junior (LF)

Department of Research and Education, National Institute of Cardiology, Rio de Janeiro, RJ, Brazil.

Gilberto Marcelo Sperandio da Silva (GM)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Paula Simplicio da Silva (PS)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Marcelo Teixeira de Holanda (MT)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Erica Rodrigues Maciel (ER)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Fernanda Martins Carneiro (FM)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Flavia Mazzoli-Rocha (F)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Luiz Henrique Conde Sangenis (LHC)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Fernanda de Souza Nogueira Sardinha Mendes (FSNS)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Alejandro Marcel Hasslocher-Moreno (AM)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Andrea Silvestre de Sousa (AS)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Andrea Rodrigues da Costa (AR)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Roberto Magalhães Saraiva (RM)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Pedro Emmanuel Alvarenga Americano do Brasil (PEAA)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Mauro Felippe Felix Mediano (MFF)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Department of Research and Education, National Institute of Cardiology, Rio de Janeiro, RJ, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH